DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
79.96
-0.21 (-0.26%)
Aug 13, 2025, 4:00 PM - Market closed
DexCom Stock Forecast
Stock Price Forecast
According to 19 professional analysts, the 12-month price target for DexCom stock ranges from a low of $85 to a high of $115. The average analyst price target of $99.89 forecasts a 24.92% increase in the stock price over the next year.
Price Target: $99.89 (+24.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 9 | 8 | 8 |
| Buy | 7 | 8 | 8 | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 19 | 20 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $106 | Strong Buy | Maintains | $106 | +32.57% | Aug 1, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $99 → $102 | Strong Buy | Maintains | $99 → $102 | +27.56% | Jul 31, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $90 → $100 | Buy | Maintains | $90 → $100 | +25.06% | Jul 31, 2025 |
| UBS | UBS | Strong Buy Maintains $105 → $106 | Strong Buy | Maintains | $105 → $106 | +32.57% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $95 → $102 | Buy | Maintains | $95 → $102 | +27.56% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
4.71B
from 4.03B
Increased by 16.74%
Revenue Next Year
5.43B
from 4.71B
Increased by 15.42%
EPS This Year
2.07
from 1.42
Increased by 45.41%
EPS Next Year
2.59
from 2.07
Increased by 24.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9B | 5.9B | 6.9B | ||
| Avg | 4.7B | 5.4B | 6.2B | ||
| Low | 4.5B | 5.0B | 5.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.5% | 24.7% | 26.9% | ||
| Avg | 16.7% | 15.4% | 14.7% | ||
| Low | 11.0% | 5.5% | -0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.25 | 3.08 | 4.11 | ||
| Avg | 2.07 | 2.59 | 3.19 | ||
| Low | 1.91 | 2.25 | 2.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.8% | 48.6% | 58.7% | ||
| Avg | 45.4% | 25.0% | 23.2% | ||
| Low | 34.2% | 8.8% | -1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.